Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clayton Hardman
Observed names:
Clayton T. Hardman,
Hardman, Clayton T.
Institution:
Arcus Biosciences (United States)
Observed institutions:
Genomics Institute of the Novartis Research Foundation,
Arcus Biosciences (United States),
Stanford University
ORCID:
0000-0001-5275-7046
Observed ORCID:
0000-0001-5275-7046
OpenAlex ID:
A5087077641
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV
2017
·
Paul A. Wender
, Clayton T. Hardman
, et al.
·
Science
·
113
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy
2020
·
Clayton Hardman
, Stephen Ho
, et al.
·
Nature Communications
·
45
PDF
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
2018
·
Matthew D. Marsden
, Xiaomeng Wu
, et al.
·
Virology
·
41
PDF
Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation
2021
·
Efrat Abramson
, Clayton Hardman
, et al.
·
Cell chemical biology
·
18
PDF
Function-Oriented Synthesis: Design, Synthesis, and Evaluation of Highly Simplified Bryostatin Analogues
2020
·
Paul A. Wender
, Jack L. Sloane
, et al.
·
The Journal of Organic Chemistry
·
13
Development of a Scalable Synthesis of Casdatifan (AB521), a Potent, Selective, Clinical-Stage Inhibitor of HIF-2α
2025
·
Clayton Hardman
, Artur K. Mailyan
, et al.
·
Organic Process Research & Development
·
7
Synthetic versatility of 2-substituted-6-methyl 2,3-dihydropyridinones in the synthesis of polyfunctional piperidine-based compounds and related β amino acid derivatives
2017
·
Yang Yang
, Clayton Hardman
·
Organic & Biomolecular Chemistry
·
7
Abstract A012: Discovery and characterization of Casdatifan (AB521), a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor
2024
·
Kenneth V. Lawson
, Artur Mailyan
, et al.
·
Molecular Cancer Therapeutics
·
3
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2α
2026
·
Artur K. Mailyan
, Guillaume Mata
, et al.
·
Journal of Medicinal Chemistry
·
2
Abstract 4042: Cbl inhibition increases the response of cytotoxic T cells to sub-optimal stimulation and drives enhanced anti-tumor responses alone or in combination with PD-1 blockade
2024
·
Livia Yamashiro
, Sachie Marubayashi
, et al.
·
Cancer Research
Abstract P206: AB521 potently and selectively inhibits pro-tumorigenic gene transcription by Hypoxia-Inducible Factor (HIF)-2α in vitro and in vivo
2021
·
Kelsey E. Sivick Gauthier
, Dana Piovesan
, et al.
·
Molecular Cancer Therapeutics
The Synthesis of Chiral Beta-Amino Acids and Beta-Lactams via Oxidative Cleavage of Chiral Dihydropyridones Derived from Vinylogous Mannich Reaction (VMR)
2017
·
Yang Yang
, Clayton Hardman
CCDC 1564674: Experimental Crystal Structure Determination
2017
·
Wender, Paul A.
, Hardman, Clayton T.
, et al.
·
The Cambridge Structural Database
Show more works
View as search
Works count:
13
Citation count:
249
H-index:
7
I10-index:
5
Year
Topic
Type